Alnylam Pharmaceuticals Inc (ALNY)
147.40
-0.49
(-0.33%)
USD |
NASDAQ |
May 15, 16:00
147.42
+0.02
(+0.01%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 18.65B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 14, 2024 | 18.71B |
| May 13, 2024 | 18.96B |
| May 10, 2024 | 19.03B |
| May 09, 2024 | 19.15B |
| May 08, 2024 | 19.26B |
| May 07, 2024 | 19.52B |
| May 06, 2024 | 19.13B |
| May 03, 2024 | 19.27B |
| May 02, 2024 | 19.01B |
| May 01, 2024 | 18.97B |
| April 30, 2024 | 18.21B |
| April 29, 2024 | 18.64B |
| April 26, 2024 | 18.13B |
| April 25, 2024 | 18.17B |
| April 24, 2024 | 18.19B |
| April 23, 2024 | 18.47B |
| April 22, 2024 | 18.44B |
| April 19, 2024 | 18.26B |
| April 18, 2024 | 18.36B |
| April 17, 2024 | 18.38B |
| April 16, 2024 | 18.55B |
| April 15, 2024 | 18.68B |
| April 12, 2024 | 18.78B |
| April 11, 2024 | 19.23B |
| April 10, 2024 | 19.27B |
| Date | Value |
|---|---|
| April 09, 2024 | 19.72B |
| April 08, 2024 | 19.73B |
| April 05, 2024 | 19.42B |
| April 04, 2024 | 19.16B |
| April 03, 2024 | 19.07B |
| April 02, 2024 | 19.10B |
| April 01, 2024 | 19.39B |
| March 28, 2024 | 18.90B |
| March 27, 2024 | 19.52B |
| March 26, 2024 | 19.22B |
| March 25, 2024 | 19.23B |
| March 22, 2024 | 18.53B |
| March 21, 2024 | 18.47B |
| March 20, 2024 | 18.64B |
| March 19, 2024 | 18.66B |
| March 18, 2024 | 18.57B |
| March 15, 2024 | 18.80B |
| March 14, 2024 | 18.71B |
| March 13, 2024 | 18.69B |
| March 12, 2024 | 18.47B |
| March 11, 2024 | 18.78B |
| March 08, 2024 | 18.87B |
| March 07, 2024 | 18.87B |
| March 06, 2024 | 18.85B |
| March 05, 2024 | 18.85B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.017B
Minimum
May 20 2019
29.69B
Maximum
Dec 21 2022
18.71B
Average
18.68B
Median
Apr 15 2024
Market Cap Benchmarks
| Pfizer Inc | 163.28B |
| BridgeBio Pharma Inc | 5.608B |
| Ionis Pharmaceuticals Inc | 5.726B |
| Johnson & Johnson | 367.48B |
| Blueprint Medicines Corp | 6.687B |
Market Cap Related Metrics
| PS Ratio | 9.341 |
| Price to Free Cash Flow | 146.40 |
| Price | 147.40 |
| Earnings Yield | -1.82% |